Collectively, HA-ADT inhibited HCC via promoting apoptosis through suppressing GSK-3β/AKT/β-catenin and inhibiting autophagy through suppressing TGF-β/Smad2/3 pathways (Duan et al., 2023). This evidence concerns the gene TGFB1 and hepatocellular carcinoma.